MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC

Martin Reck, Ernest Nadal, Nicolas Girard, Andrea Riccardo Filippi, Linda W. Martin, Carl M. Gay, Cordula Petersen, Davina Gale, Ugochinyere Emeribe, Nefeli Georgoulia, Ignacio Esteban Díaz Pérez, Jonathan Spicer